Therapeutic Advances in Chronic Disease

该期刊采用CRediT（贡献者角色分类法）来描述每位作者对工作的具体贡献，投稿时需列出每位作者的贡献，并在提交中于致谢部分之后加入“作者贡献”标题。 模型中文摘要

As part of our commitment to ensuring an ethical, transparent and fair peer review and publication process, this journal has adopted CRediT (Contributor Roles Taxonomy). CRediT is a high-level taxonomy, including 14 roles, which is used to describe each author’s individual contributions to the work. You will be asked to list the contribution of each author as part of the submission process. Please…

该期刊鼓励作者在符合伦理和法律要求的前提下，将研究数据存入相关公共数据仓库，并附上数据可用性声明链接至数据；若无法共享数据，需在声明中说明原因，并在研究中引用该数据。 模型中文摘要

The Journal is committed to facilitating openness, transparency and reproducibility of research, and has the following research data sharing policy. For more information, including FAQs please visit the Sage Research Data policy pages. Subject to appropriate ethical and legal considerations, authors are encouraged to: Share your research data in a relevant public data repository Include a data ava…

作者需在指定标题下提供伦理批准声明，即使方法部分已包含该信息；若无需伦理批准，也须明确说明。涉及人类参与者、人类数据或人体组织的研究，必须声明相关伦理委员会或机构审查委员会批准或豁免，并提供委员会全名、机构及批准编号。 模型中文摘要

Please include your ethics approval statements under this heading, even if you have already included ethics approval information in your methods section. If ethical approval was not required, you need to explicitly state this. All papers reporting studies involving human participants, human data or human tissue must state that the relevant Ethics Committee or Institutional Review Board approved th…

Sage Open Chronic Disease 是开放获取、同行评审期刊，所有被接受的文章在出版后立即免费在线发布，采用知识共享许可并永久在线托管；稿件经同行评审被接受后需支付一次性文章处理费（APC），标准APC为3200美元，由资助方、机构或作者支付，投稿本身不收费。 模型中文摘要

Sage Open Chronic Disease is an open access, peer-reviewed journal. All accepted articles are made freely available online immediately upon publication, are published under a Creative Commons license, and hosted online in perpetuity. If, after peer review, your manuscript is accepted for publication, a one-time article processing charge (APC) is payable to cover the cost of publishing, paid by the…

该期刊采用单盲同行评审，审稿人与编辑互动，不公布审稿信息；稿件先经初步评估，不符合指南要求会被退回修改，若超出范围或不合适可能在同行评审前被直接拒稿，通过初步评估后进入同行评审。 模型中文摘要

The following summary describes the peer review process for this journal: Identity transparency: Single-anonymized Reviewer interacts with: Editor Review information published: None Your manuscript will undergo an initial evaluation. If it does not conform to the requirements laid out in these guidelines, it will be returned to you for amendments prior to peer review. Manuscripts may be desk rejec…

该期刊和Sage高度重视版权侵权、抄袭及其他违反出版最佳实践的行为，作者应阅读Sage完整的抄袭政策及可能采取的措施。 模型中文摘要

The journal and Sage take issues of copyright infringement, plagiarism or other breaches of best practice in publication very seriously. Please read Sage's complete policy on plagiarism and the actions we may take.

该期刊接受已在预印本服务器上发布的稿件，投稿时需在指定字段填写预印本DOI，并建议在投稿时告知期刊编辑部；同行评审期间不应在预印本服务器上发布更新版本。 模型中文摘要

The journal will consider submissions of manuscripts that have been posted on preprint servers. Please enter the preprint DOI in the designated field when submitting your manuscript. We advise that you inform the Journal Editorial office about your posted preprint at submission. Note that you should not post an updated version of your manuscript on a preprint server while it is being peer reviewed…

该期刊遵循ICMJE要求，临床试验须在首次招募参与者时或之前在WHO认可的公共试验注册机构注册，作为考虑发表的条件；试验注册名称、URL和注册号须附在摘要末尾，但符合AllTrials运动精神，若延迟注册的理由可接受，回顾性注册的试验也会被考虑。 模型中文摘要

The journal conforms to the ICMJE requirement that clinical trials are registered in a WHO-approved public trials registry at or before the time of first participant enrollment as a condition of consideration for publication. The trial registry name and URL, and registration number must be included at the end of the abstract. The journal endorses the ICMJE requirement that clinical trials are regi…